Dexamethasone effectively reduces postoperative nausea for patients receiving neuraxial morphine for cesarean delivery and hysterectomy, according to a study in the April issue of Anesthesia & Analgesia.
The Latest
I-Flow today announced the launch of a new suite of ON-Q T-bloc kits and trays for use in regional nerve block procedures. The ON-Q T-bloc, which includes needles, catheters and other pain management accessories, is intended for continuous upper and…
Researchers have identified a major gene affecting chronic pain sensitivity, according to a study reported in News-Medical.
Insys Therapeutics has launched Subsys fentanyl sublingual spray to manage recurring cancer pain, according to Pharmaceutical Business Review.
Gastroenterologist Daniel J. Pambianco, MD, writes about ACG's recently updated guidelines for colorectal screening and the importance of routine colonoscopy screening in a Daily Progress article.
A new study conducted by gastroenterologists at the Washington University School of Medicine in St. Louis indicates poor preparation by patients for a colonoscopy may lead to doctors missing pre-cancerous polyps, according to a news release.
Approximately 15 Health Management Associates hospitals have implemented new technology designed to prevent patient falls, according to a Naples News report. Read the full report in Becker’s Hospital Review on patient falls.
Hospitals’ quality improvement efforts may lead to an initial decline in patient satisfaction, according to researchers at Ohio State University. Read the full report in Becker’s Hospital Review on quality improvement and the patient experience.
Saint Catherine Medical Center Fountain Springs in Ashland is prohibited from accepting new patients after state officials discovered “serious deficiencies and violations” that they said threatened patient safety, according to a Republican Herald report. Read the full report in Becker’s…
U.S. Senators Michael Bennet (D-Colo.), Orrin Hatch (R-Utah) and Richard Burr (R-N.C.) introduced a bipartisan bill that would expedite FDA approval and provide more flexibility when a drug or treatment shows dramatic responses early in development, while still ensuring drug…